Lowy: NCI to focus on multi-cancer detection tests, diversity in workforce, clinical trials

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

As NCI prepares for a transition of leadership, Acting Director Douglas Lowy is setting out an agenda focused on multi-cancer detection tests, undruggable targets, cell therapy, and on eliminating disparities caused by persistent poverty.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Matthew Bin Han Ong
Matthew Bin Han Ong
Table of Contents

YOU MAY BE INTERESTED IN

Matthew Bin Han Ong
Matthew Bin Han Ong

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login